Table S2. Performance, physiological, and perceptual measures of males and females for both conditions (pBFR, BFR). Data are expressed in means ± standard deviations.
|
|
pBFR |
BFR |
| Males |
Females |
Males |
Females |
| Systolic
blood flow velocity [cm·s-1] |
32.2 ±
9.0 |
25.0 ±
9.6 |
31.5 ±
9.5 |
27.2 ±
7.6 |
| Maximal
voluntary torque |
Pre
[Nm] |
315.3
± 52.4 |
194.1
± 35.1 |
313.7
± 51.8 |
202.2
± 34.3 |
| Post [Nm] |
189.1 ±
77.5 |
158.6 ±
41.7 |
209.0 ±
85.1 |
145.1 ±
49.2 |
| Percentage
decline [%] |
34.6
± 23.4 |
25.9
± 20.5 |
40.3
± 23.5 |
21.9
± 13.4 |
| Maximal
muscle activity |
Pre [μV] |
433.1 ±
124.6 |
282.1 ±
61.0 |
433.6 ±
132.0 |
293.0 ±
97.4 |
| Post
[μV] |
349.8
± 111.1 |
246.1
± 81.7 |
357.8
± 143.4 |
263.7
± 96.3 |
| Percentage
decline [%] |
15.8 ±
23.8 |
13.5 ±
17.7 |
18.7 ±
18.8 |
8.2 ±
22.2 |
| Muscle
activity during exercise [% of sEMG-MVIC at pre-test] |
Set
1 |
25.7
± 5.5 |
32.4
± 8.0 |
25.3
± 4.8 |
31.6
± 7.0 |
| Set 2 |
27.8 ±
7.2 |
32.9 ±
9.7 |
29.2 ±
7.2 |
32.3 ±
7.5 |
| Set
3 |
30.9
± 8.1 |
36.7
± 10.9 |
33.4
± 9.3 |
35.3
± 9.4 |
| Set 4 |
33.0 ±
10.4 |
40.8 ±
12.9 |
37.4 ±
11.1 |
38.4 ±
9.6 |
| SmO2
during sets [%-change from baseline] |
Set
1 |
-72.6
± 15.7 |
-32.0
± 27.0 |
-70.8
± 17.3 |
-33.1
± 20.9 |
| Set 2 |
-76.8 ±
15.0 |
-31.9 ±
22.9 |
-75.4 ±
15.3 |
-35.4 ±
20.8 |
| Set
3 |
-77.0
± 14.2 |
-35.5
± 24.7 |
-76.4
± 17.2 |
-40.7
± 17.0 |
| Set 4 |
-76.7 ±
13.5 |
-39.3 ±
22.3 |
-75.9 ±
13.7 |
-43.6 ±
16.0 |
| SmO2
during rest intervals [%-change from baseline] |
Rest
1 |
-56.4
± 18.4 |
-23.0
± 17.7 |
-60.4
± 15.8 |
-25.1
± 16.5 |
| Rest 2 |
-55.0 ±
16.2 |
-24.0 ±
19.0 |
-61.2 ±
14.2 |
-30.5 ±
14.8 |
| Rest
3 |
-55.2
± 15.3 |
-26.6
± 18.8 |
-60.8
± 11.7 |
-34.0
± 13.9 |
| tHb
during sets [%-change from baseline] |
Set 1 |
0.6 ±
1.6 |
1.9 ±
1.9 |
1.2 ±
1.1 |
3.4 ±
1.3 |
| Set
2 |
1.5
± 1.0 |
3.4
± 1.5 |
1.7
± 1.4 |
3.9
± 1.8 |
| Set 3 |
1.6 ±
1.1 |
4.0 ±
1.6 |
1.9 ±
1.3 |
4.4 ±
1.7 |
| Set
4 |
1.3
± 2.5 |
4.3
± 1.6 |
2.1
± 1.5 |
5.9
± 1.7 |
| tHb
during rest intervals [%-change from baseline] |
Rest 1 |
0.7 ±
2.2 |
3.3 ±
1.6 |
1.5 ±
1.1 |
4.1 ±
1.6 |
| Rest
2 |
0.9
± 2.2 |
3.8
± 1.7 |
1.8
± 1.3 |
5.1
± 1.9 |
| Rest 3 |
1.0 ±
2.9 |
4.2 ±
1.7 |
2.0 ±
1.3 |
5.7 ±
1.9 |
| Effort
perception [a. u.] |
Set
1 |
12.7
± 2.4 |
13.9
± 2.0 |
13.3
± 1.8 |
12.7
± 1.4 |
| Set 2 |
14.3 ±
1.6 |
14.7 ±
2.3 |
14.9 ±
2.0 |
13.3 ±
1.4 |
| Set
3 |
16.0
± 1.2 |
15.3
± 2.3 |
16.1
± 2.3 |
14.6
± 1.7 |
| Set 4 |
17.3 ±
1.9 |
16.0 ±
2.0 |
17.4 ±
2.1 |
15.3 ±
2.1 |
| Exercise-induced
leg muscle pain perception [a. u.] |
Set
1 |
12.3
± 2.3 |
12.7
± 2.5 |
12.6
± 2.3 |
12.5
± 1.9 |
| Set 2 |
14.3 ±
2.1 |
13.9 ±
2.1 |
14.7 ±
2.6 |
13.6 ±
1.6 |
| Set
3 |
15.9
± 2.1 |
15.3
± 2.2 |
16.4
± 2.7 |
15.1
± 2.2 |
| Set 4 |
17.1 ±
2.6 |
16.1 ±
2.0 |
17.6 ±
2.5 |
16.0 ±
2.1 |
| Cuff
pressure-induced discomfort perception [a. u.] |
Pre |
1.5
± 1.3 |
1.7
± 1.5 |
2.0
± 1.0 |
2.5
± 1.7 |
| Post |
2.8 ±
2.7 |
2.0 ±
1.2 |
3.8 ±
3.0 |
3.3 ±
1.7 |
|
a.u., arbitrary unit; sEMG, surface electromyography; MVIC, maximal isometric voluntary contraction; SmO2, muscle oxygen saturation; tHb, total hemoglobin |
|